• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将数字测量与早期帕金森病中的有意义症状和影响相关联。

Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson's Disease.

机构信息

University of Rhode Island, College of Nursing, Providence, RI, USA.

Critical Path Institute, Tucson, AZ, USA.

出版信息

J Parkinsons Dis. 2023;13(4):589-607. doi: 10.3233/JPD-225122.

DOI:10.3233/JPD-225122
PMID:37212073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10357170/
Abstract

BACKGROUND

Adoption of new digital measures for clinical trials and practice has been hindered by lack of actionable qualitative data demonstrating relevance of these metrics to people with Parkinson's disease.

OBJECTIVE

This study evaluated of relevance of WATCH-PD digital measures to monitoring meaningful symptoms and impacts of early Parkinson's disease from the patient perspective.

METHODS

Participants with early Parkinson's disease (N = 40) completed surveys and 1:1 online-interviews. Interviews combined: 1) symptom mapping to delineate meaningful symptoms/impacts of disease, 2) cognitive interviewing to assess content validity of digital measures, and 3) mapping of digital measures back to personal symptoms to assess relevance from the patient perspective. Content analysis and descriptive techniques were used to analyze data.

RESULTS

Participants perceived mapping as deeply engaging, with 39/40 reporting improved ability to communicate important symptoms and relevance of measures. Most measures (9/10) were rated relevant by both cognitive interviewing (70-92.5%) and mapping (80-100%). Two measures related to actively bothersome symptoms for more than 80% of participants (Tremor, Shape rotation). Tasks were generally deemed relevant if they met three participant context criteria: 1) understanding what the task measured, 2) believing it targeted an important symptom of PD (past, present, or future), and 3) believing the task was a good test of that important symptom. Participants did not require that a task relate to active symptoms or "real" life to be relevant.

CONCLUSION

Digital measures of tremor and hand dexterity were rated most relevant in early PD. Use of mapping enabled precise quantification of qualitative data for more rigorous evaluation of new measures.

摘要

背景

新的数字措施在临床试验和实践中的采用受到阻碍,因为缺乏可操作的定性数据来证明这些指标与帕金森病患者的相关性。

目的

本研究从患者的角度评估了 WATCH-PD 数字措施对监测早期帕金森病的有意义症状和影响的相关性。

方法

40 名早期帕金森病患者(N=40)完成了问卷调查和 1:1 的在线访谈。访谈结合了:1)症状映射,以描绘疾病的有意义症状/影响;2)认知访谈,以评估数字措施的内容有效性;3)将数字措施映射回个人症状,以评估从患者角度的相关性。使用内容分析和描述性技术来分析数据。

结果

参与者认为映射非常投入,有 39/40 名参与者报告说能够更好地沟通重要症状和措施的相关性。大多数措施(9/10)在认知访谈(70-92.5%)和映射(80-100%)中都被评为相关。与超过 80%的参与者的主动困扰症状相关的两项措施(震颤、形状旋转)。如果任务符合三个参与者情境标准,则通常被认为是相关的:1)理解任务测量的内容;2)相信它针对 PD 的重要症状(过去、现在或将来);3)相信该任务是对该重要症状的良好测试。参与者不需要任务与主动症状或“真实”生活相关才能相关。

结论

震颤和手部灵巧性的数字措施在早期 PD 中被评为最相关。使用映射可以对定性数据进行精确量化,以便更严格地评估新措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/10357170/248071b500fe/jpd-13-jpd225122-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/10357170/ee6d81d63ea8/jpd-13-jpd225122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/10357170/956c21cd0287/jpd-13-jpd225122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/10357170/7555eab95aec/jpd-13-jpd225122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/10357170/9109b4ffc3b6/jpd-13-jpd225122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/10357170/248071b500fe/jpd-13-jpd225122-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/10357170/ee6d81d63ea8/jpd-13-jpd225122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/10357170/956c21cd0287/jpd-13-jpd225122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/10357170/7555eab95aec/jpd-13-jpd225122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/10357170/9109b4ffc3b6/jpd-13-jpd225122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/10357170/248071b500fe/jpd-13-jpd225122-g005.jpg

相似文献

1
Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson's Disease.将数字测量与早期帕金森病中的有意义症状和影响相关联。
J Parkinsons Dis. 2023;13(4):589-607. doi: 10.3233/JPD-225122.
2
Relative Meaningfulness and Impacts of Symptoms in People with Early-Stage Parkinson's Disease.早期帕金森病患者症状的相对意义和影响。
J Parkinsons Dis. 2023;13(4):619-632. doi: 10.3233/JPD-225068.
3
Patient Experience in Early-Stage Parkinson's Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment.早期帕金森病患者的体验:运用混合方法分析确定哪些概念对临床试验结果评估至关重要。
Neurol Ther. 2022 Sep;11(3):1319-1340. doi: 10.1007/s40120-022-00375-3. Epub 2022 Jul 1.
4
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease.基于技术的客观测量可检测未经治疗的新发帕金森病的亚临床轴症状。
J Parkinsons Dis. 2020;10(1):113-122. doi: 10.3233/JPD-191758.
5
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
6
Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson's.开发并初步验证两种新型患者报告结局工具,以评估早期帕金森病患者的日常功能。
J Patient Rep Outcomes. 2023 Apr 20;7(1):40. doi: 10.1186/s41687-023-00577-9.
7
Understanding what aspects of Parkinson's disease matter most to patients and families.了解帕金森病的哪些方面对患者和家属最重要。
Sci Rep. 2024 Sep 11;14(1):21171. doi: 10.1038/s41598-024-71555-4.
8
Role of data measurement characteristics in the accurate detection of Parkinson's disease symptoms using wearable sensors.使用可穿戴传感器准确检测帕金森病症状的数据测量特征的作用。
J Neuroeng Rehabil. 2020 Apr 20;17(1):52. doi: 10.1186/s12984-020-00684-4.
9
A Wearable Vibratory Device (The Emma Watch) to Address Action Tremor in Parkinson Disease: Pilot Feasibility Study.一种用于解决帕金森病动作性震颤的可穿戴振动装置(艾玛手表):初步可行性研究
JMIR Biomed Eng. 2023 Oct 23;8:e40433. doi: 10.2196/40433.
10
Improved measurement of disease progression in people living with early Parkinson's disease using digital health technologies.使用数字健康技术改善早期帕金森病患者疾病进展的测量。
Commun Med (Lond). 2024 Mar 15;4(1):49. doi: 10.1038/s43856-024-00481-3.

引用本文的文献

1
Perspective Mapping: Tutorial for Collecting Quantifiable Qualitative Interview Data.视角映射:收集可量化定性访谈数据的教程
J Med Internet Res. 2025 Aug 14;27:e72622. doi: 10.2196/72622.
2
Advancing the Integration of Digital Health Technologies in the Drug Development Ecosystem.推动数字健康技术在药物开发生态系统中的整合。
J Med Internet Res. 2025 Jul 31;27:e67052. doi: 10.2196/67052.
3
Digital Health in Parkinson's Disease and Atypical Parkinsonism-New Frontiers in Motor Function and Physical Activity Assessment: Review.

本文引用的文献

1
Assessing real-world gait with digital technology? Validation, insights and recommendations from the Mobilise-D consortium.利用数字技术评估真实世界的步态?Mobilise-D 联盟的验证、见解和建议。
J Neuroeng Rehabil. 2023 Jun 14;20(1):78. doi: 10.1186/s12984-023-01198-5.
2
An Interview With the Food and Drug Administration About Draft Patient-Focused Drug Development Guidance 3: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments.对美国食品药品监督管理局就《以患者为中心的药物研发指南3:选择、开发或修改适用的临床结局评估》草案的访谈
Value Health. 2023 Jun;26(6):791-795. doi: 10.1016/j.jval.2023.04.006. Epub 2023 Apr 26.
3
帕金森病和非典型帕金森综合征中的数字健康——运动功能与身体活动评估的新前沿:综述
J Clin Med. 2025 Jun 11;14(12):4140. doi: 10.3390/jcm14124140.
4
Using machine learning to identify Parkinson's disease severity subtypes with multimodal data.利用机器学习通过多模态数据识别帕金森病严重程度亚型。
J Neuroeng Rehabil. 2025 Jun 2;22(1):126. doi: 10.1186/s12984-025-01648-2.
5
Developing digital health technologies for frontotemporal degeneration.开发用于额颞叶痴呆的数字健康技术。
Alzheimers Dement. 2025 Apr;21(4):e70082. doi: 10.1002/alz.70082.
6
Modernizing the Staging of Parkinson Disease Using Digital Health Technology.利用数字健康技术实现帕金森病分期的现代化。
J Med Internet Res. 2025 Apr 4;27:e63105. doi: 10.2196/63105.
7
Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson's.对早期帕金森病患者有意义症状的纵向定性评估以及WATCH-PD数字测量的相关性。
J Neurol. 2025 Jan 15;272(2):114. doi: 10.1007/s00415-024-12789-0.
8
Characterizing Hand Function in Parkinson's Disease Patients with a Self-Administered Electronic Manual Dexterity Test.通过自我管理的电子手动灵巧性测试来表征帕金森病患者的手部功能。
Mov Disord Clin Pract. 2025 Mar;12(3):333-339. doi: 10.1002/mdc3.14286. Epub 2024 Nov 27.
9
Accelerating Parkinson's Disease drug development with federated learning approaches.利用联邦学习方法加速帕金森病药物研发。
NPJ Parkinsons Dis. 2024 Nov 21;10(1):225. doi: 10.1038/s41531-024-00837-5.
10
Implementing sensor-based digital health technologies in clinical trials: Key considerations from the eCOA Consortium.在临床试验中实施基于传感器的数字健康技术:eCOA 联盟的主要考虑因素。
Clin Transl Sci. 2024 Nov;17(11):e70054. doi: 10.1111/cts.70054.
Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease.
罗氏 PD 移动应用程序远程监测早期帕金森病的可靠性和有效性。
Sci Rep. 2022 Jul 15;12(1):12081. doi: 10.1038/s41598-022-15874-4.
4
Patient Experience in Early-Stage Parkinson's Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment.早期帕金森病患者的体验:运用混合方法分析确定哪些概念对临床试验结果评估至关重要。
Neurol Ther. 2022 Sep;11(3):1319-1340. doi: 10.1007/s40120-022-00375-3. Epub 2022 Jul 1.
5
Body-Worn Sensors for Parkinson's disease: A qualitative approach with patients and healthcare professionals.可穿戴式传感器在帕金森病中的应用:一项针对患者和医疗保健专业人员的定性研究
PLoS One. 2022 May 5;17(5):e0265438. doi: 10.1371/journal.pone.0265438. eCollection 2022.
6
Self-Report versus Clinician Examination in Early Parkinson's Disease.帕金森病早期的自我报告与临床检查。
Mov Disord. 2022 Mar;37(3):585-597. doi: 10.1002/mds.28884. Epub 2021 Dec 13.
7
Mobile devices and wearable technology for measuring patient outcomes after surgery: a systematic review.用于测量术后患者预后的移动设备和可穿戴技术:一项系统评价
NPJ Digit Med. 2021 Nov 12;4(1):157. doi: 10.1038/s41746-021-00525-1.
8
A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson's Disease: A Qualitative Study.以患者为中心的早期帕金森病症状及其影响的概念模型:一项定性研究。
J Parkinsons Dis. 2022;12(1):137-151. doi: 10.3233/JPD-202457.
9
The emerging clinical role of wearables: factors for successful implementation in healthcare.可穿戴设备在临床领域的新角色:医疗保健领域成功应用的因素
NPJ Digit Med. 2021 Mar 10;4(1):45. doi: 10.1038/s41746-021-00418-3.
10
Digital Health Technology to Measure Drug Efficacy in Clinical Trials for Parkinson's Disease: A Regulatory Perspective.数字健康技术在帕金森病临床试验中测量药物疗效:监管视角。
J Parkinsons Dis. 2021;11(s1):S111-S115. doi: 10.3233/JPD-202416.